6-(1H-Pyrazol-1-yl)pyrimidin-4-amine

6-(1H-Pyrazol-1-yl)-4-pyrimidinamine is a reagent used in the selective α7 nAChR partial agonist for the treatment of cognitive deficits associated with schizophrenia